Chinese biotech startup receives $80 M in Series B funding

Ansun Biopharma , which is committed to developing first-in-class innovative biopharmaceuticals for ...

October 15, 2019 | Tuesday | News
WuXi AppTec brings new chemical space of tangible molecules

WuXi AppTec Research Service Division and BioSolveIT have launched a new virtual chemical space called GalaXi®. Larg...

October 16, 2019 | Wednesday | News
CMAB Biopharma establishes exclusive partnership with BJ Bioscience

CMAB Biopharma (Suzhou) Inc., a pure-play biologics CDMO and BJ Bioscience Inc., an innovative biopharmaceutical enterpr...

October 14, 2019 | Monday | News
Innovent, Chi-Med expand global collaboration for solid tumor treatment

Innovent Biologics, Inc. and Hutchison China MediTech Limited (Chi-Med) have announced the expansion of their global col...

October 11, 2019 | Friday | News
CTFH, Insilico Medicine enter Al drug discovery collaboration

Insilico Medicine, a Hong Kong headquartered company developing an end-to-end drug discovery pipeline utilizing the late...

October 10, 2019 | Thursday | News
Ascletis appoints new Chief Scientific Officer

Ascletis Pharma, an innovative R&D driven, commercial-stage biotechnology company addressing unmet medical needs in ...

October 9, 2019 | Wednesday | News
Chipscreen, Novogene team up to develop companion diagnostics

Chipscreen Biosciences Co., Ltd. and Novogene Co., Ltd. recently announced a strategic partnership for companion diagnos...

October 9, 2019 | Wednesday | News
I-Mab novel antibody gets IND approval in China

I-Mab Biopharma, a China and U.S.-based clinical stage biopharmaceutical company exclusively focused on the di...

October 8, 2019 | Tuesday | News
CNMPA approves Agilent's PD-L1 Companion Diagnostic

Agilent Technologies has announced that the National Medical Products Administration (NMPA, formerly the China...

October 7, 2019 | Monday | News
CanSino partners with Ocugen to work on gene therapy

Ocugen, Inc., a UK based clinical stage biopharmaceutical company focused on innovative therapies that address rare and ...

October 2, 2019 | Wednesday | News
Eisai, Nichi-Iko explore generic pharma biz in China

Japan headquartered Eisai Co., Ltd. and Nichi-Iko Pharmaceutical have announced that they have entered into a comprehens...

October 1, 2019 | Tuesday | News
Simcere, JW Pharma join hands for anti-gout drug candidate

China based Simcere Pharmaceutical Group and Korea headquartered JW Pharmaceutical have announced a collaboration and ex...

September 30, 2019 | Monday | News
Fang Chunming proposes 3 initiatives to speed up medical pilot zones construction

The Fangchenggang International Medical Opening-up Pilot Zone (China) Strategic Dialogue Conference was held in Nanning,...

September 27, 2019 | Friday | News
Thermo Fisher with Frontier Bio to develop novel HIV treatment

Thermo Fisher Scientific Inc., the world leader in serving science, announced collaboration with Frontier Biotechno...

September 27, 2019 | Friday | News
Thermo Fisher expands clinical trials capabilities in China

Thermo Fisher Scientific, the world leader in serving science, announced an expansion of its integrated clinical trials ...

September 26, 2019 | Thursday | News
Chinese startup CareVoice officially launches CareVoiceOS

The CareVoice, an international health insurtech company based in China, who recently closed an eight-figure USD Series ...

September 26, 2019 | Thursday | News
Blue Sail Medical enters into structural heart market

China based Blue Sail Medical recently announced that the company made a purchase offer to acquire a...

September 26, 2019 | Thursday | News
PolyU develops new class of antibiotic candidates against superbugs

The Hong Kong Polytechnic University (PolyU) has developed a new class of antibiotic drug candidates which has high pote...

September 25, 2019 | Wednesday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls